Markets:

Overview

News

Currencies

International

Treasuries

(TSV:TELO)

0.0450 UNCHANGED

Streaming Delayed Price Updated: 11:55 AM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about TELO

Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th

December 05, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference

August 05, 2025

From Virtual Investor Conferences

Via GlobeNewswire

OTCQB Venture Virtual Investor Conference: Presentations Now Available for Online Viewing

August 08, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation

October 26, 2023

Toronto, Ontario--(Newsfile Corp. - October 26, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce...

Via Newsfile

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

October 17, 2023

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

OTCQB Venture Virtual Investor Conference Agenda Announced for August 7th

August 04, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Telo Genomics Announces Achieving Interim Results from Smouldering Myeloma Clinical Study

September 14, 2022

Toronto, Ontario--(Newsfile Corp. - September 14, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") is...

Via Newsfile

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

Telo Genomics Announces Full-Services Investor Relations Agreement with Adelaide Capital

September 21, 2021

Toronto, Ontario--(Newsfile Corp. - September 21, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") is pleased to...

Via Newsfile

Topics Artificial Intelligence

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

From FN Media Group LLC

Via GlobeNewswire

Telo Genomics Participates in the 18th International Myeloma Society Workshop 2021

September 09, 2021

Toronto, Ontario--(Newsfile Corp. - September 9, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") is pleased to...

Via Newsfile

Topics Artificial Intelligence

Telo Genomics Engages Clinical and Regulatory Affairs Veteran to Lead the Company's ISO 15189 Certification & CLIA Laboratory Accreditation Undertaking

August 09, 2021

Toronto, Ontario--(Newsfile Corp. - August 9, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") is pleased to...

Via Newsfile

Topics Artificial Intelligence

Telo Genomics Completes First Tranche of Oversubscribed Private Placement

July 02, 2021

Toronto, Ontario--(Newsfile Corp. - July 2, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") announces that it...

Via Newsfile

Topics Artificial Intelligence

Telo Genomics Announces Co-Authored Publication of a Prospective 5-year Multiple Myeloma Study - Successfully Identifying High Risk versus Low Risk Smoldering Myeloma Patients

April 29, 2021

Toronto, Ontario--(Newsfile Corp. - April 29, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") is pleased to...

Via Newsfile

Topics Artificial Intelligence

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.